SCHEMBL6153606

SCHEMBL6153606

CS(=O)(=O)c1cccc(C2(CC#N)CCN(C(=O)O)CC2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.40
JAK2 O60674 3/20 0.39
JAK1 P23458 3/20 0.39
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
PKLR P30613 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRL1 P41146 2/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
CCR5 P51681 2/20 0.35
CACNA1B Q00975 1/20 0.35
DRD2 P14416 3/20 0.35
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3524300 0.85 JAK2 (0.53) JAK2JAK1NR1H2NR1H3
SCHEMBL27621499 0.81 JAK2 (0.39) CNR2JAK2JAK1NR1H2NR1H3
SCHEMBL3526611 0.81 ALDH1A1 (0.48) OPRM1OPRL1ALDH1A1
SCHEMBL3525622 0.79 KMT2A (0.53) ALDH1A1HSD17B10
SCHEMBL3530638 0.72 SLC6A4 (0.43) JAK2JAK1
SCHEMBL3529341 0.72 SLC6A3 (0.43) JAK2JAK1ALDH1A1GAA
SCHEMBL3528335 0.72 SLC6A3 (0.43) JAK2JAK1
Tert-Butyl Formate SCHEMBL27621500 0.71 JAK2 (0.35) CNR2JAK2JAK1OPRM1OPRL1
SCHEMBL3530123 0.71 APP (0.43) JAK2JAK1OPRM1OPRL1
SCHEMBL3528131 0.69 JAK2 (0.50) JAK2JAK1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569646-A2 PIPERIDINE DERIVATIVES AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2005-09-07 EP disclosed
WO-2004054974-A2 PIPERIDINE DERIVATIVES AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2004-07-01 WO disclosed